For the period (end-June 30, 2021), NanoString had total revenues of $33.6 million, up from $21.1 million in the second quarter of 2020. The company reported instrument revenue of $11.8 million, which included $7.4 million of GeoMx digital spatial profiler instrument revenue.

NanoString had a second-quarter net loss of $18.6 million compared with a net loss of $23 million from the same period a year ago.

NanoString releases nCounter stem cell characterization panel
NanoString Technologies has unveiled its nCounter stem cell characterization panel for the analysis and optimization of stem cell lines for humans and...

NanoString posts higher revenues, lower net loss in Q1
Strong growth in product and service revenues helped NanoString Technologies reach 18.8% total revenue growth and a lower net loss in its first quarter.

NanoString tech used to develop SARS-CoV-2 lung cell atlas
NanoString Technologies' GeoMX digital spatial profiler (DSP) technology has been used to develop a foundational dataset to better understand the biological...

AACR 2021: Single-cell technologies bring new insights to tumor cells
Single-cell technologies have become important tools for cancer researchers and provide scientists with the ability to make measurements of individual...

NanoString increases access to spatial molecular imager
NanoString Technologies has launched a technology access program for its spatial molecular imager.